Rivar Teva

/ SLE

Dosage must be adjusted individually according to the patient’s medical condition. Please refer to the patient leaflet for the complete information.

Rivaroxaban 2.5 mg:
Rivaroxaban 2.5 mg, co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers.
Rivaroxaban 2.5 mg, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischaemic events.
Rivaroxaban 10 mg:
Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery.
Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), in adults (following completion of at least 6 months therapy for DVT or PE).
Rivaroxaban 15 mg and 20 mg:
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, prior stroke or transient ischaemic attack.
Treatment of deep vein thrombosis (DVT), and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.

Hypersensitivity to rivaroxaban or to any of the other ingredients.
Excessive bleeding.
Disease or condition in an organ of the body that increases the risk of serious bleeding (such as: stomach ulcer, injury or bleeding in the brain, recent surgery of the brain or eyes).
Concomitant treatment with other anticoagulants (e.g. warfarin, dabigatran, apixaban or heparin), except under specific circumstances of changing from one anticoagulant to another or while receiving heparin through a venous or arterial line to keep it open.
Liver disease which leads to an increased risk of bleeding.
Pregnancy or breastfeeding.
Please refer to the patient leaflet for the complete information.

Please refer to the patient leaflet for the complete information.

Please refer to the patient leaflet for the complete information.

Please refer to the patient leaflet for the complete information.

Please refer to the patient leaflet for the complete information.

Please refer to the patient leaflet for the complete information.

Doses of 15 mg and 20 mg must be taken with food and
swallowed with water.
This medicinal product may cause dizziness (a common side effect) or fainting (an uncommon side effect). Do not drive, ride a bicycle, use tools or operate machinery while using this medicinal product if you experience these symptoms.